Compare MAGN & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAGN | SLP |
|---|---|---|
| Founded | 1864 | 1996 |
| Country | United States | United States |
| Employees | 2980 | N/A |
| Industry | Paper | EDP Services |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.4M | 370.7M |
| IPO Year | 1994 | 1996 |
| Metric | MAGN | SLP |
|---|---|---|
| Price | $12.56 | $18.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $12.00 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 451.3K | 149.2K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $3,204,000,000.00 | $59,577,000.00 |
| Revenue This Year | $5.37 | $3.80 |
| Revenue Next Year | $3.47 | $5.90 |
| P/E Ratio | ★ N/A | $42.77 |
| Revenue Growth | ★ 46.50 | 10.52 |
| 52 Week Low | $7.82 | $11.09 |
| 52 Week High | $15.52 | $21.01 |
| Indicator | MAGN | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 62.05 |
| Support Level | $11.64 | $18.22 |
| Resistance Level | $12.96 | $18.57 |
| Average True Range (ATR) | 0.48 | 0.03 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 59.46 | 83.33 |
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.